These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32633873)

  • 1. Nonalcoholic fatty liver disease is associated with a decreased myocardial mechano-energetic efficiency.
    Fiorentino TV; Miceli S; Succurro E; Sciacqua A; Andreozzi F; Sesti G
    J Intern Med; 2021 Feb; 289(2):221-231. PubMed ID: 32633873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic Syndrome and C-reactive Protein are Associated With a Reduced Myocardial Mechano-energetic Efficiency.
    Cefalo CMA; Riccio A; Fiorentino TV; Succurro E; Miceli S; Mannino GC; Perticone M; Sciacqua A; Andreozzi F; Sesti G
    J Clin Endocrinol Metab; 2023 Oct; 108(11):e1264-e1271. PubMed ID: 37235788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depressed myocardial mechano-energetic efficiency in subjects with dysglycemia.
    Vanessa Fiorentino T; Miceli S; Succurro E; Sciacqua A; Andreozzi F; Sesti G
    Diabetes Res Clin Pract; 2021 Jul; 177():108883. PubMed ID: 34082055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
    Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
    Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between liver fibrosis and decreased myocardial mechano-energetic efficiency in individuals with different degree of glucose tolerance.
    Riccio A; Mazzanti C; Vero L; Vanessa Fiorentino T; Succurro E; Miceli S; Perticone M; Sciacqua A; Andreozzi F; Cefalo CMA; Sesti G
    Diabetes Res Clin Pract; 2023 May; 199():110639. PubMed ID: 36963509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial mechano-energetic efficiency and insulin resistance in non-diabetic members of the Strong Heart Study cohort.
    Mancusi C; de Simone G; Best LG; Wang W; Zhang Y; Roman MJ; Lee ET; Howard BV; Devereux RB
    Cardiovasc Diabetol; 2019 Apr; 18(1):56. PubMed ID: 31039789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between remnant lipoprotein cholesterol levels and non-alcoholic fatty liver disease in adolescents.
    Chin J; Mori TA; Adams LA; Beilin LJ; Huang RC; Olynyk JK; Ayonrinde OT
    JHEP Rep; 2020 Dec; 2(6):100150. PubMed ID: 32984791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender impacts on the correlations between nonalcoholic fatty liver disease and hypertension in a Chinese population aged 45-60 y.
    Li XD; Qiu BH; Su FC; Sun SX
    Clin Exp Hypertens; 2016; 38(7):639-643. PubMed ID: 27680771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin Resistance and Non-Alcoholic Fatty Liver Disease in Premenopausal Women with Metabolic Syndrome.
    El-Sehrawy AA; State O; Elzehery RR; Mohamed AS
    Horm Metab Res; 2021 Feb; 53(2):100-104. PubMed ID: 33513642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole blood viscosity is associated with reduced myocardial mechano-energetic efficiency in nondiabetic individuals.
    Riccio A; Cefalo CMA; Mazzanti C; Vero L; Fiorentino TV; Massimino M; Monea G; Succurro E; Perticone M; Sciacqua A; Andreozzi F; Sesti G
    Eur J Clin Invest; 2024 Mar; 54(3):e14127. PubMed ID: 37950492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance.
    Yang KC; Hung HF; Lu CW; Chang HH; Lee LT; Huang KC
    Sci Rep; 2016 Jun; 6():27034. PubMed ID: 27246655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of non-alcoholic steatohepatitis with subclinical myocardial dysfunction in non-cirrhotic patients.
    Lee YH; Kim KJ; Yoo ME; Kim G; Yoon HJ; Jo K; Youn JC; Yun M; Park JY; Shim CY; Lee BW; Kang SM; Ha JW; Cha BS; Kang ES
    J Hepatol; 2018 Apr; 68(4):764-772. PubMed ID: 29175242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diastolic dysfunction and cardiovascular risk in old subjects: possible association with NAFLD?
    Gianotti G; Cenni A; Bianchi G; Masetti M; Zappoli P; Muscari A; Zoli M;
    Arch Gerontol Geriatr; 2014; 58(2):188-95. PubMed ID: 24268461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High red blood cell distribution width is closely associated with nonalcoholic fatty liver disease.
    Yang W; Huang H; Wang Y; Yu X; Yang Z
    Eur J Gastroenterol Hepatol; 2014 Feb; 26(2):174-8. PubMed ID: 24025980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Better association of waist circumference with insulin resistance and some cardiovascular risk factors than body mass index.
    Elbassuoni E
    Endocr Regul; 2013 Jan; 47(1):3-14. PubMed ID: 23363252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Study of Serum Homocysteine and Non-Alcoholic Fatty Liver Disease in Euglycemic Patients.
    Hu Y; Liu J; Dong X; Xu Y; Leng S; Wang G
    Med Sci Monit; 2016 Nov; 22():4146-4151. PubMed ID: 27803497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between increased alanine aminotransferase activity and metabolic factors in nonalcoholic fatty liver disease.
    Oh SY; Cho YK; Kang MS; Yoo TW; Park JH; Kim HJ; Park DI; Sohn CI; Jeon WK; Kim BI; Son BH; Shin JH
    Metabolism; 2006 Dec; 55(12):1604-9. PubMed ID: 17142131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between vascular inflammation and non-alcoholic fatty liver disease: Analysis by
    Lee HJ; Lee CH; Kim S; Hwang SY; Hong HC; Choi HY; Chung HS; Yoo HJ; Seo JA; Kim SG; Kim NH; Baik SH; Choi DS; Choi KM
    Metabolism; 2017 Feb; 67():72-79. PubMed ID: 28081780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial dysfunction is associated with reduced myocardial mechano-energetic efficiency in drug-naïve hypertensive individuals.
    Cefalo CMA; Riccio A; Fiorentino TV; Rubino M; Mannino GC; Succurro E; Perticone M; Sciacqua A; Andreozzi F; Sesti G
    Intern Emerg Med; 2023 Nov; 18(8):2223-2230. PubMed ID: 37755541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-alcoholic fatty liver disease is associated with cardiovascular disease in subjects with different glucose tolerance.
    Fiorentino TV; Succurro E; Sciacqua A; Andreozzi F; Perticone F; Sesti G
    Diabetes Metab Res Rev; 2020 Nov; 36(8):e3333. PubMed ID: 32356922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.